WOLVERINE is a multi-peptide research formulation of BPC-157 and TB-500. These peptides are individually investigated for their involvement in tissue repair, cellular migration, inflammatory signaling and extracellular matrix remodeling.
| Title |
|---|
| 4 vials (15% discount) |
| 8 vials (25% discount) |
| 12 vials (35% disocunt) |
WOLVERINE is a multi-peptide research formulation of BPC-157 and TB-500. These peptides are individually investigated for their involvement in tissue repair, cellular migration, inflammatory signaling and extracellular matrix remodeling.
BPC-157 is a synthetic pentadecapeptide investigated primarily in preclinical research examining tissue protection, angiogenesis and cellular responses to injury. Experimental studies have explored its interactions with fibroblast activity, nitric oxide-associated signaling and gastrointestinal tissue biology.
TB-500 – Thymosin Beta-4 research particularly biological processes involving actin regulation, cellular migration and tissue remodeling. Full-length Thymosin Beta-4 has been investigated in wound healing, angiogenesis and inflammatory regulation.
WOLVERINE 10 mg is presented as a research formulation for laboratory and scientific applications. The stated quantity refers to the total peptide content and should not be interpreted as a recommended human dosage.
Product: WOLVERINE
Strength: 10 mg total
Expected composition: BPC-157 5mg + TB-500 5mg
Category: Recovery
Compound classification: Experimental multi-peptide research formulation
Research target: Tissue repair-associated pathways, actin regulation, cellular migration and inflammatory signaling
Research focus: Tissue remodeling, wound healing, angiogenesis, fibroblast activity and cellular responses to injury
Mechanism: Combines peptides individually investigated for their involvement in tissue repair-associated signaling, cytoskeletal regulation and cellular migration
Intended use: Laboratory and research use only
Associated with Thymosin Beta-4, a naturally occurring peptide involved in tissue repair, wound healing and cellular regeneration. Research explores its role in cell migration, blood vessel formation (angiogenesis), inflammatory regulation and tissue remodeling, including recovery in muscle, tendon, skin and cardiovascular tissue.
A tripeptide corresponding to the C-terminal sequence Lys-Pro-Val associated with ฮฑ-MSH biology. Research interest centres on cellular signalling involved in inflammatory and immune-regulatory processes.
A combined formulation intended for studying multiple signalling components within one experimental system, BPC-157 + TB-500 + GHK-Cu + KPV blend.
A multi-component research formulation combining peptides associated with cellular repair, extracellular-matrix signalling and tissue-remodelling research. The final page should identify every component and its exact amount rather than marketing GLOW as a single molecular entity.
A synthetic 15-amino-acid peptide extensively investigated in preclinical models involving cellular protection, vascular signalling and tissue-repair biology. Despite considerable experimental interest, human clinical evidence remains limited and no approved therapeutic formulation exists.
A synthetic peptide derived from the helix-B region of erythropoietin (EPO), investigated for tissue-protective signalling without reproducing EPOโs erythropoietic activity. Its research landscape includes inflammatory regulation, cellular protection and tissue-repair signalling pathways.